You are here

Bavencio

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

Endpoints

Sat, 02/17/18 - 10:44 am

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

Yahoo/Reuters

Thu, 02/15/18 - 10:09 am

clinical trials

Pfizer sweeps out a lineup of neuroscience drugs — as well as cancer and NASH programs — into the scrap heap

Endpoints

Tue, 01/30/18 - 09:52 am

Pfizer defends kidney-cancer position with Bavencio 'breakthrough'

Fierce Pharma

Wed, 01/3/18 - 10:58 am

Array Biopharma ties up with Pfizer on cancer-fighting combos

Fierce Biotech

Wed, 12/20/17 - 09:51 am

Array Biopharma

clinical trials

Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study

Endpoints

Tue, 11/28/17 - 10:11 am

Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod

Yahoo/Reuters

Thu, 09/21/17 - 08:38 am

Merkel cell carcinoma

Can Pfizer Bank on New Immunotherapy Bavencio for Growth?

Yahoo/Zacks.com

Fri, 08/18/17 - 12:01 am

immuno-oncology

renal cell carcinoma

head and neck cancer

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda

RAPS.org

Sat, 07/22/17 - 12:23 pm

Lexicon Pharmaceuticals

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Wed, 05/10/17 - 09:31 am

Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor

BioPharma Dive

Sun, 03/26/17 - 12:00 pm

Pages